1. Home
  2. INGR vs TFX Comparison

INGR vs TFX Comparison

Compare INGR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingredion Incorporated

INGR

Ingredion Incorporated

HOLD

Current Price

$104.74

Market Cap

6.3B

ML Signal

HOLD

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$138.74

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGR
TFX
Founded
1906
1943
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.8B
IPO Year
1997
1994

Fundamental Metrics

Financial Performance
Metric
INGR
TFX
Price
$104.74
$138.74
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$128.57
$138.75
AVG Volume (30 Days)
600.8K
581.2K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.94%
1.02%
EPS Growth
15.14
N/A
EPS
4.01
2.08
Revenue
$7,219,000,000.00
$1,992,713,000.00
Revenue This Year
$3.86
$15.97
Revenue Next Year
$2.95
$5.15
P/E Ratio
$26.19
$67.39
Revenue Growth
N/A
N/A
52 Week Low
$94.44
$100.18
52 Week High
$130.48
$145.00

Technical Indicators

Market Signals
Indicator
INGR
TFX
Relative Strength Index (RSI) 53.92 57.16
Support Level $98.04 $128.36
Resistance Level $106.46 $145.00
Average True Range (ATR) 1.55 3.66
MACD -0.05 0.31
Stochastic Oscillator 41.73 87.91

Price Performance

Historical Comparison
INGR
TFX

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins. The company plans to acquire Tate & Lyle in an all-cash deal that should close in 2027.

About TFX Teleflex Incorporated

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

Share on Social Networks: